A Study of NKTR-214 Combined With Nivolumab vs Nivolumab Alone in Participants With Previously Untreated Inoperable or Metastatic Melanoma
Clinical trial NCT03635983 · COMPLETED
Trial details
- NCT number
- NCT03635983
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-09-21
- Primary completion
- 2021-11-19
- Enrollment
- 783
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.